FIELD: medicine. SUBSTANCE: method involves mixing erythropoietin with urea and a mixture of aminoacids with added polyethylene sorbitane laurate taken in definite quantities. Erythropoietin dose is 100-50000 units. The end phase involves sterilizing filtration and lyophilization. EFFECT: improved stability of the medicinal preparation. 2 cl, 3 tbl
Authors
Dates
1995-09-10—Published
1988-09-05—Filed